March 12th 2025
Rivaroxaban, long known under the brand name Xarelto, is an anticoagulant, a classification that is among the most-prescribed medications in the United States.
February 17th 2025
Flowsheet Models Modernize Pharmaceutical Manufacturing Design and Risk Assessment
In-silico design facilitates process optimization and evaluation of process control strategies.
Development Progresses in Continuous Solid-Dosage Manufacturing
December 17th 2014FDA funded projects at Rutgers' C-SOPS and at UMass Lowell to develop flow-sheet model algorithms for use in risk assessment, and start-up company Continuus Pharmaceuticals is making progress on their integrated system.